Chen Y, Yeh T, Hsu H, Lane H, Lu S, Ma W
BMC Psychiatry. 2025; 25(1):187.
PMID: 40033277
PMC: 11874657.
DOI: 10.1186/s12888-025-06643-4.
Bonnett L, Hunt A, Flores A, Tudur Smith C, Varese F, Byrne R
Schizophrenia (Heidelb). 2025; 11(1):29.
PMID: 40011470
PMC: 11865318.
DOI: 10.1038/s41537-025-00582-5.
Pelizza L, Di Lisi A, Leuci E, Quattrone E, Palmisano D, Pupo S
Hum Psychopharmacol. 2025; 40(2):e70003.
PMID: 39962036
PMC: 11832455.
DOI: 10.1002/hup.70003.
Germanenko I, Vrublevska J, Bezborodovs N, Rancans E
Early Interv Psychiatry. 2024; 19(1):e13625.
PMID: 39511931
PMC: 11730073.
DOI: 10.1111/eip.13625.
Hunt A, Law H, Carney R, Mulholland R, Flores A, Tudur Smith C
Front Psychiatry. 2024; 15:1408738.
PMID: 39415891
PMC: 11480010.
DOI: 10.3389/fpsyt.2024.1408738.
Resting-state electroencephalogram in drug-free subjects with at-risk mental states who later developed psychosis: a low-resolution electromagnetic tomography analysis.
Higuchi Y, Odagiri S, Tateno T, Suzuki M, Takahashi T
Front Hum Neurosci. 2024; 18:1449820.
PMID: 39257698
PMC: 11384587.
DOI: 10.3389/fnhum.2024.1449820.
Case series of patients with early psychosis presenting hypoperfusion in angular gyrus and self-disturbance: Implication for the sense of agency and schizophrenia.
Yoshikawa A, Obata Y, Kakiuchi C, Nakanishi A, Kimura S, Aoki S
Neuropsychopharmacol Rep. 2024; 44(4):706-715.
PMID: 39212170
PMC: 11609757.
DOI: 10.1002/npr2.12476.
The Relationship between Clinical and Psychophysical Assessments of Visual Perceptual Disturbances in Individuals at Clinical High Risk for Psychosis: A Preliminary Study.
Ifrah C, Herrera S, Silverstein S, Corcoran C, Gordon J, Butler P
Brain Sci. 2024; 14(8).
PMID: 39199510
PMC: 11352348.
DOI: 10.3390/brainsci14080819.
Distress Related to Attenuated Psychotic Symptoms: Static and Dynamic Association With Transition to Psychosis, Nonremission, and Transdiagnostic Symptomatology in Clinical High-Risk Patients in an International Intervention Trial.
Nelson B, Yuen H, Amminger G, Berger G, Chen E, de Haan L
Schizophr Bull Open. 2024; 3(1):sgaa006.
PMID: 39144772
PMC: 11205873.
DOI: 10.1093/schizbullopen/sgaa006.
Sleep disruptions and the pathway to psychosis: An in-depth case and literature review.
Kim J, Prasad S, Roshan N, Hasan B, Gill G, Gunturu S
Clin Case Rep. 2024; 12(6):e9108.
PMID: 38887308
PMC: 11180692.
DOI: 10.1002/ccr3.9108.
Factorial structure of the Comprehensive Assessment of At-Risk Mental States in help-seeking individuals: mapping the structure and the prediction of subsequent transition to psychosis.
Montemagni C, Carluccio A, Brasso C, Vischia F, Rocca P
Front Psychiatry. 2024; 15:1381133.
PMID: 38855646
PMC: 11157954.
DOI: 10.3389/fpsyt.2024.1381133.
The Comparison of Lifestyles, Mental Risks, and Physical Indices among Individuals with Ultra-High Risk of Psychosis, Patients with Schizophrenia, and the General Public.
Tsai C, Chu C, Lane H, Chen S, Tu C, Ma W
Behav Sci (Basel). 2024; 14(5).
PMID: 38785886
PMC: 11118771.
DOI: 10.3390/bs14050395.
Neuropsychology and Neurobiology of Negative Schizotypy: A Selective Review.
Wang L, Lui S, Chan R
Biol Psychiatry Glob Open Sci. 2024; 4(4):100317.
PMID: 38711865
PMC: 11070600.
DOI: 10.1016/j.bpsgos.2024.100317.
Race/ethnicity and socioeconomic status as predictors of outcome following family therapy in youth at clinical high risk for psychosis.
Ruiz-Yu B, Le T, Weintraub M, Zinberg J, Addington J, OBrien M
Early Interv Psychiatry. 2024; 18(12):981-990.
PMID: 38676463
PMC: 11512687.
DOI: 10.1111/eip.13541.
Distinct Volume Alterations of Thalamic Nuclei Across the Schizophrenia Spectrum.
Thalhammer M, Schulz J, Scheulen F, Oubaggi M, Kirschner M, Kaiser S
Schizophr Bull. 2024; 50(5):1208-1222.
PMID: 38577901
PMC: 11349018.
DOI: 10.1093/schbul/sbae037.
Heterogeneity of clinical symptomatology in pediatric patients at clinical high risk for psychosis.
Rintell L, Carroll D, Wales M, Gonzalez-Heydrich J, DAngelo E
BMC Res Notes. 2024; 17(1):88.
PMID: 38532408
PMC: 10964501.
DOI: 10.1186/s13104-024-06742-7.
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.
Wannan C, Nelson B, Addington J, Allott K, Anticevic A, Arango C
Schizophr Bull. 2024; 50(3):496-512.
PMID: 38451304
PMC: 11059785.
DOI: 10.1093/schbul/sbae011.
Identification of distinct clinical profiles and trajectories in individuals at high risk of developing psychosis: A latent profile analysis of the north American prodrome longitudinal study consortium-3 dataset.
Berge D, Carter C, Smucny J
Early Interv Psychiatry. 2024; 18(9):739-749.
PMID: 38351643
PMC: 11323210.
DOI: 10.1111/eip.13514.
An exploratory study of psychosis risk factors in individuals who are referred but do not meet criteria for an early intervention in psychosis service.
Naughton S, Brady A, Geary E, Counihan E, Clarke M
BJPsych Open. 2024; 10(1):e21.
PMID: 38179675
PMC: 10790220.
DOI: 10.1192/bjo.2023.640.
Combinations and Temporal Associations Among Precursor Symptoms Before a First Episode of Psychosis.
Paquin V, Malla A, Iyer S, Lepage M, Joober R, Shah J
Schizophr Bull. 2023; 50(4):860-870.
PMID: 37861419
PMC: 11283192.
DOI: 10.1093/schbul/sbad152.